LIFEVANTAGE CORP

LFVN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $42.4M $43.7M $48.9M $47.6M $55.1M $58.4M $67.8M $47.2M
Cost of Revenue $9.3M $9.2M $12.7M $9.7M $11.1M $11.1M $13.2M $9.5M
Gross Profit $33.0M $34.5M $36.2M $37.8M $44.0M $47.3M $54.6M $37.7M
Gross Margin 78.0% 79.0% 74.0% 79.5% 79.9% 81.0% 80.5% 79.9%
Operating Expenses
Research & Development $300.0K $200.0K $200.0K $300.0K $500.0K $400.0K $200.0K $300.0K
SG&A Expense $13.9M $13.9M $15.8M $14.9M $18.7M $17.1M $18.6M $14.8M
Operating Income $1.7M $1.7M $487.0K $2.3M $2.1M $4.1M $3.4M $2.6M
Operating Margin 3.9% 3.8% 1.0% 4.8% 3.9% 6.9% 5.1% 5.4%
Interest Expense — — — — — — — —
Pretax Income $1.7M $1.7M $473.0K $2.2M $2.4M $4.2M $3.1M $2.6M
Income Tax Expense $417.0K $294.0K $197.0K $86.0K $437.0K $710.0K $539.0K $752.0K
Net Income $1.3M $1.4M $276.0K $2.2M $2.0M $3.5M $2.6M $1.8M
Net Margin 3.0% 3.1% 0.6% 4.5% 3.6% 5.9% 3.8% 3.9%
EPS (Basic) $0.10 $0.11 $0.02 $0.17 $0.16 $0.28 $0.21 $0.15
EPS (Diluted) $0.10 $0.11 $0.02 $0.17 $0.16 $0.26 $0.19 $0.14
Shares Outstanding (Basic) 12.5M 12.6M 12.6M 12.4M 12.3M 12.4M 12.2M 12.2M
Shares Outstanding (Diluted) 12.7M 12.7M 12.7M 12.9M 13.0M 13.3M 13.2M 12.8M
Dividends Per Share $0.05 $0.05 $0.05 $0.05 $0.05 $0.04 $0.04 $0.04
← Newer Page 1 of 8 Older →